High circulating osteoprotegerin levels are associated with non-zero blood groups

Association of plasma osteoprotegerin levels with the severity of lower extremity arterial disease in patients with type 2 diabetes

(2015) Yixin Niu et al.   BMC Cardiovascular Disorders

The intriguing relationship between the ABO blood group, cardiovascular disease, and cancer

(2015) Massimo Franchini et al.   BMC Medicine

Epidemiology of Peripheral Artery Disease

(2015) M. H. Criqui et al.   CIRCULATION RESEARCH

Vascular calcification: from pathophysiology to biomarkers

(2015) Séverine Evrard et al.   CLINICA CHIMICA ACTA

Von Willebrand factor in relation to coronary plaque characteristics and cardiovascular outcome

(2015) Michelle A. Sonneveld et al.   THROMBOSIS AND HAEMOSTASIS

Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings?

(2014) Susanne Elisabeth Hosbond et al.   ATHEROSCLEROSIS

Of von Willebrand factor and platelets

(2014) Marijke Bryckaert et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Influence of pre-analytical and analytical factors on osteoprotegerin measurements

(2014) C. Pérez de Ciriza et al.   CLINICAL BIOCHEMISTRY

ABO blood group and thrombotic vascular disease

(2014) Pier Mannuccio Mannucci et al.   THROMBOSIS AND HAEMOSTASIS

Associations of Candidate Biomarkers of Vascular Disease with the Ankle-Brachial Index and Peripheral Arterial Disease

(2013) Z. Ye et al.   AMERICAN JOURNAL OF HYPERTENSION

An ELISA for the quantitation of von Willebrand Factor: Osteoprotegerin complexes in plasma

(2013) Pernille J. Vinholt et al.   THROMBOSIS RESEARCH

Role of the OPG/RANK/RANKL triad in calcifications of the atheromatous plaques: Comparison between carotid and femoral beds

(2012) Marie-Françoise Heymann et al.   CYTOKINE

Osteoprotegerin as a marker of atherosclerosis: A systematic update

(2012) Susanne Elisabeth Hosbond et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Plasma osteoprotegerin is related to carotid and peripheral arterial disease, but not to myocardial ischemia in type 2 diabetes mellitus

(2011) Mikael K Poulsen et al.   Cardiovascular Diabetology

Osteoprotegerin is associated with cardiovascular risk in hypertension and/or diabetes

(2011) Ana M. Blázquez-Medela et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Osteoprotegerin is higher in peripheral arterial disease regardless of glycaemic status

(2010) Eoin P. O'Sullivan et al.   THROMBOSIS RESEARCH

Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites

(2009) Zeenat Ali et al.   ATHEROSCLEROSIS

Lysine-specific gingipain promotes lipopolysaccharide- and active-vitamin D3-induced osteoclast differentiation by degrading osteoprotegerin

(2008) Rika Yasuhara et al.   BIOCHEMICAL JOURNAL

Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-α levels in men with type 2 diabetes

(2008) Subhashini Yaturu et al.   CYTOKINE

Serum osteoprotegerin is associated with carotid intima media thickness in women with previous gestational diabetes

(2008) Baris Akinci et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Circulating Osteoprotegerin Levels and Long-Term Prognosis in Patients With Acute Coronary Syndromes

(2008) Torbjørn Omland et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

N-linked glycosylation of VWF modulates its interaction with ADAMTS13

(2007) T. A. J. McKinnon et al.   BLOOD